How does myTomorrows ensure high quality patient referrals to trial sites?

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

1 mins read

share this post

myTomorrows can ensure a thorough pre-screening process for our clients’ trials, conducted by our medically trained patient navigators using the latest technology. We gather essential required information from patients, and where applicable their physicians, to build an accurate and compliant medical profile. Via our ISO-27001-certified platform, we share these pseudonymized profiles with trial sites, for them to directly assess the benefit of an on-site screening visit.

This streamlined process minimizes the burden on trial sites and time better spent during on-site screenings, ultimately improving efficiency of clinical trial recruitment processes.

share this post

raymond.vanderwaal@mytomorrows.com 12 Jan 2024

more articles

view all blogs
Michel van Harten AWS Pioneers
AI

myTomorrows Joins AWS Pioneers Project 2026

myTomorrows Team

18 Mar 2026

7 mins read

myTomorrows Trust Center blog

myTomorrows Trust Center: Security, Compliance, and Transparency

Filippo Mandrini

19 Feb 2026

9 mins read

Man with ALS performing physical therapy
ALS
Neurological disorders
Physical Therapy

The Role of Physical Therapy in ALS Care

Andrea Enguita

14 Jan 2026

16 mins read

Medical researchers
Rare Disease
MAP

Sentynl Selects myTomorrows to Lead Managed Access Program

myTomorrows Team

15 Dec 2025

4 mins read

Clinical Trials
HCPs
Oncology
Trial sites

Whitepaper: Advancing Neuro-Oncology Clinical Trial Access

Daniël Groeneweg

27 Nov 2025

8 mins read

Person with end-stage Parkinson's and caregiver
Neurological disorders
Parkinson's disease
End-stage Parkinson's

End-Stage Parkinson’s Disease: Symptoms, Care, and Support

Andrea Enguita

18 Nov 2025

21 mins read

Trial sites
Clinical Trials
Clinical researchers
Referrals

Getting Started: myTomorrows Referral Platform for Site Staff

Adrianne Rivard

14 Nov 2025

10 mins read

myTomorrows Avego finding announcement
Patient Access
Investment
Funding

Our next chapter: €25M growth investment to scale patient access worldwide

Michel van Harten

11 Nov 2025

7 mins read

ALS patient flow
ALS Clinical Trials
BioPharma
Expanded Access Programs

Accelerating ALS Clinical Trial Recruitment in the U.S.

Dennis Akkaya

10 Oct 2025

12 mins read

Vanessa Lemarie
Tech
Award
Innovation

myTomorrows’ COO Vanessa Lemarié Named in Sifted’s Top 100 Women in Tech Europe

Michel van Harten

10 Oct 2025

2 mins read